Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
VanEck Oil Services ETF
OIH
5
ProShares Ultra Energy
DIG
US Stock MarketDetailed Quotes
Spero Therapeutics (SPRO)
- 2.850
- +0.150+5.56%
Close Jun 12 16:00 ET
- 2.850
- 0.0000.00%
Post 18:30 ET
165.02MMarket Cap10.56P/E (TTM)
2.850High2.700Low623.94KVolume2.720Open2.700Prev Close1.74MTurnover1.34%Turnover Ratio19.00P/E (Static)57.90MShares3.22052wk High3.12P/B132.59MFloat Cap1.80052wk Low--Dividend TTM46.52MShs Float23.639Historical High--Div Yield TTM5.56%Range %0.505Historical Low2.787Avg Price1Lot Size
Spero Therapeutics (SPRO) Key Financial Indicators
SPRO Earnings per Share (EPS)
According to the latest financial report of Spero Therapeutics, the latest earnings per share (TTM) for the company is -0.13. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
SPRO Free Cash Flow (FCF)
Interested in knowing about Spero Therapeutics's free cash flow? The latest report shows it as 15.86M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
SPRO Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Spero Therapeutics shows that the company's current ratio is 10.50, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
SPRO Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Spero Therapeutics, the quick ratio is 10.23, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
SPRO Return on Equity (ROE)
Want to learn more about the financial health of Spero Therapeutics? The latest ROE figure is -12.87%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
SPRO Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Spero Therapeutics, the total asset return on investment (ROA) is -11.26%.
Currency: USD
Quarterly
Loading...
SPRO Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Spero Therapeutics's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
SPRO Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Spero Therapeutics, the net profit margin is -2.79K%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
The more than three-month-long U.S.-Iran war has finally come to an end! Pakistani Prime Minister Shehbaz announced on Sunday that the Unite
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm